By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

6042 Cornerstone Court W,

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a



Company News
Sorrento And Its Wholly-Owned Subsidiary, TNK Therapeutics, To Exclusively License CytoLumina's NanoVelcro Circulating Tumor Cell Profiling Assay 8/11/2015 7:03:06 AM
Sorrento Unit Buys CAR-T Programs, Technology for Undisclosed Sum 8/10/2015 6:12:03 AM
Sorrento In-Licenses Four Late-Stage Clinical Biobetter And Biosimilar Antibodies 8/3/2015 6:38:10 AM
Top Sorrento Exec Quits to Take Helm at Unnamed Startup 7/20/2015 6:03:59 AM
Globavir Biosciences, Inc. Exclusively Licenses Oncology Program To Sorrento 7/9/2015 9:28:46 AM
Sorrento Added To Russell 2000 Small Cap, Russell 3000 And Global Indexes 6/29/2015 12:41:50 PM
ARK Animal Health, A Subsidiary Of Sorrento, Announces Receipt Of MUMS Drug Designation In Dogs 6/24/2015 10:42:43 AM
Sorrento To Present At The 2015 Jefferies and Co. Healthcare Conference And At Other Conferences 5/26/2015 10:12:41 AM
Advaxis, Inc. And Sorrento Form Collaboration To Evaluate Combinations Of Advaxis's Lm-LLO Immunotherapy Technology And Sorrento's Immunomodulatory Antibodies 5/19/2015 8:20:15 AM
Sorrento Establishes TNK Therapeutics Subsidiary With Focus On Cellular Immunotherapies 5/18/2015 7:23:14 AM